# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 591
- **Admission ID**: 154785
- **Row ID**: 12745
- **Profile Type**: FULL

## Demographics

- **Age**: 77
- **Sex**: M
- **Date of Birth**: 2084-05-19
- **Ethnicity**: WHITE
- **Marital Status**: MARRIED
- **Religion**: UNOBTAINABLE
- **Insurance**: Medicare
- **Admission Type**: EMERGENCY
- **Admission Date**: 2161-12-01 14:25:00
- **Discharge Date**: 2161-12-21 15:00:00

## Chief Complaint

Chest discomfort.

## Symptoms

- **chest discomfort** | duration: 1 week
- **shortness of breath** | duration: 1 week
- **nausea** | duration: 1 week
- **vomiting** | duration: 1 week
- **sub-sternal chest pain that awoke him from sleep** | onset: morning of admission
- **confusion with periods of lucidity** | onset: immediate post-operative period
- **atrial fibrillation** | onset: POD 3 | duration: intermittent, with recurrence on POD 15
- **edema and weight gain (10 kg up from pre-op weight)** | onset: POD 6 | duration: several days, improved by discharge

## Medical History

Diabetes type 2. Hypertension. Asthma.

## Current Medications

- **Lasix** | dosage: 80mg | frequency: daily | purpose: Diuresis
- **HCTZ** | dosage: unknown | frequency: unknown
- **Allopurinol** | dosage: unknown | frequency: unknown
- **Protonix** | dosage: unknown | frequency: unknown
- **Advair** | dosage: unknown | frequency: unknown
- **Insulin** | dosage: unknown | frequency: unknown

## Discharge Medications

- **Docusate Sodium** | dosage: 100 mg | frequency: PO BID
- **Aspirin** | dosage: 81 mg | frequency: PO DAILY
- **Pantoprazole Sodium** | dosage: 40 mg | frequency: PO Q24H
- **Atorvastatin Calcium** | dosage: 20 mg | frequency: PO DAILY
- **Allopurinol** | dosage: 100 mg
- **Metoprolol Tartrate 25 mg Tablet** | dosage: 25 mg | frequency: One tablet PO BID (2 times a day)
- **Amiodarone HCl 200 mg Tablet** | dosage: 200 mg | frequency: Two tablets PO daily for 7 days, then decrease dose to 200 mg daily
- **Hydrocodone-Acetaminophen 5-500 mg Tablet** | dosage: 5-500 mg | frequency: One tablet PO Q6H (every 6 hours) as needed
- **Furosemide 80 mg Tablet** | dosage: 80 mg | frequency: One tablet PO daily
- **Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device** | dosage: 250-50 mcg/dose | frequency: One disk with device inhalation (2 times a day)

## Diagnoses

- **Coronary artery disease (3 vessel disease with significant stenoses)** | notes: 80% left main, 80% LAD, 50% LCx, 90% RCA
- **Carotid artery stenosis (left 70-79%)** | notes: Bilateral carotid bruits on exam
- **Type 2 diabetes mellitus** | notes: Past medical history
- **Hypertension** | notes: Past medical history
- **Asthma** | notes: Past medical history
- **Coronary artery disease requiring CABG** | notes: Underwent CABG x3 with LIMA to LAD, SVG to Diag, SVG to PDA and PLB
- **Atrial fibrillation** | notes: Occurred post-operatively, treated with amiodarone and beta blockers
- **Chronic renal insufficiency** | notes: Pre-op creatinine 1.9, post-op elevations up to 2.8, stable at discharge
- **Edema/volume overload** | notes: 10 kg weight gain post-op, treated with diuretics
- **COPD and asthma** | notes: History noted, beta blockers used cautiously
- **Coronary artery disease** | notes: Discharge diagnosis
- **IDDM** | notes: Discharge diagnosis
- **HTN** | notes: Discharge diagnosis

## Treatment Options

### Coronary artery bypass grafting (CABGx4)

**Details**: LIMA to LAD, SVG to Diagonal, PDA, PLV
**Treatment**: Surgical revascularization

### CABG x3

**Details**: LIMA to LAD, SVG to Diag, SVG to PDA and PLB; total bypass time 78 min, cross clamp 49 min

### Diuresis

**Details**: Lasix and natracor for volume overload; natracor discontinued POD 12, lasix continued
**Treatment**: Diuresis for edema and renal insufficiency

**Medications**:
- Lasix (not provided)
- Natracor (not provided)

### Atrial fibrillation management

**Details**: Amiodarone IV and PO, low-dose beta blockers, hydralazine for HTN
**Treatment**: Rate and rhythm control

**Medications**:
- Amiodarone (not provided)
- Lopressor (metoprolol) (not provided)
- Hydralazine (not provided)

### Blood glucose control

**Details**: NPH insulin started on POD 4
**Treatment**: Blood glucose management

**Medications**:
- NPH insulin (not provided)

### Physical therapy and rehabilitation placement

**Details**: Physical therapy throughout hospitalization; recommended for rehabilitation placement
**Treatment**: Rehabilitation
